Rockville, MD, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Fact.MR, a leading market research company, in its newly published research report, reveals that the Global AI in Diagnostics Market is estimated to reach a valuation of US$ 1.85 billion in 2024 and further expand at a high-value CAGR of 23.1% from 2024 to 2034.
Artificial intelligence (AI) is being increasingly sought after in diagnostics, revolutionizing patient care and making diagnostic services all the more accurate and efficient. Healthcare professionals are adopting AI technology for its ability to swiftly and accurately analyze complex medical data. This AI-driven approach reduces test result wait times significantly, enabling quicker diagnoses and earlier treatment initiation. Faster turnaround times for pathology reports and radiology scans are linked to improved outcomes and higher patient satisfaction.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10297
Beyond benefiting individual patients, the precision and efficiency of AI-assisted diagnostics allow medical institutions to manage larger patient volumes. This expanded capability makes diagnostic services more accessible to a broader population. As awareness grows about the speed and accuracy of AI-enhanced tests, more patients are seeking clinics that offer these advanced diagnostics. Increased demand is leading to greater investment in AI diagnostic tools, fostering innovation and broader acceptance in the healthcare sector.
Key Takeaways from Market Study:
- The global AI in diagnostics market is estimated to jump to a size of US$ 14.76 billion in 2034.
- The Canada market is forecasted to expand at a CAGR of 27.5% through 2034.
- The market for artificial intelligence in diagnostics in North America is analyzed to increase at a CAGR of 22% between 2024 and 2034.
- The South Korea market is projected to expand at a CAGR of 29.8% from 2024 to 2034.
- Based on different applications of AI, the oncology segment is estimated to hold a market share of 26.8% in 2024.
“Early detection of diseases and faster processing of medical data is helping doctors help patients with reduced emergencies. This trend is contributing to AI in diagnostics market growth,” says a Fact.MR analyst.
Leading Players Driving Innovation in the AI in Diagnostics Market:
Key industry participants like GE Healthcare; Imagen Technologies; Accenture; Deloitte; Cognizant; IBM Services; Infosys; Capgemini; Tata Consultancy Services (TCS); Wipro; Atos; DXC Technology; IBM Corporation; Google LLC; Microsoft Corporation; Butterfly Network; Zebra Medical Vision; Paige.AI; IDx Technologies; Prognos; Siemens Healthcare; Qure.ai., etc. are driving the AI in diagnostics industry.
Increased Use of Advanced Machine Learning and Language Processing:
Modern machine learning algorithms can now analyze medical images with previously unheard-of precision, identifying minute anomalies that would go unnoticed by human observers. This skill is especially revolutionary in the early diagnosis of neurological diseases and cancer.
Advances in natural language processing allow AI to quickly sort through enormous volumes of unstructured medical data, extracting critical information that helps with quicker, more accurate diagnosis. Furthermore, real-time health monitoring and early warning systems for ailments like cardiac rhythms and difficulties from diabetes are made possible by the integration of AI with wearable technology. These advancements in technology are cutting down on diagnostic mistakes and speeding up the period between the onset of symptoms and the start of therapy. Improved recovery rates and general health outcomes are the consequence of patients receiving more prompt and focused therapies.
AI is being used by healthcare systems worldwide more widely because of its demonstrable advantages in speeding up the healing process. This is encouraging further investment and innovation in this quickly developing industry.
AI in Diagnostics Industry News:
- Nutra Green Biotechnology Co., Ltd., Wolfson Berg Limited, Varion Lifesciences Pvt. Ltd., Sabinsa Corporation, and Cymbio Pharma Pvt. Ltd. are some of the key players in the forskolin market known for their strong distribution networks and innovation capabilities. Leading forskolin manufacturers employ strategies such as new product launches, mergers & acquisitions, collaborations & partnerships, and regional expansions to earn high profits.
- Cymbio Pharma Pvt. Ltd. is one of the trusted and prominent companies offering a large array of Coleus Extract. The company’s products are well-known for their high nutritional content and purity.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=10297
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the AI in diagnostics market for 2019 to 2023 and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on component (software, hardware, services), application (cardiology, oncology, pathology, radiology, pulmonology, neurology, obstetrics/gynecology), modality (MRI, CT, X-ray, ultrasound), technology (machine learning, deep learning, natural language processing, computer vision, predictive analytics), and end use (hospitals, diagnostics imaging centers, diagnostics laboratories), across seven major regions of the world (North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA).
Segmentation of AI in Diagnostics Market Research
- By Component :
- Software
- Hardware
- Services
- By Application :
- Cardiology
- Oncology
- Pathology
- Radiology
- Pulmonology
- Neurology
- Obstetrics/Gynecology
- By Modality :
- MRIs
- CT
- X-rays
- Ultrasound
- By Technology :
- Machine Learning
- Deep Learning
- Natural Language Processing
- Computer Vision
- Predictive Analytics
Check out More Related Studies Published by Fact.MR Research:
Brain monitoring devices market is currently valued at US$ 6.5 billion and is expected to increase at a noteworthy CAGR of 6% to reach US$ 8.7 billion by the end of 2027.
Knee cartilage repair market is predicted to evolve at a CAGR of 5% from 2022 to 2027. In 2022, the market stands at a valuation of US$ 3.92 billion and is expected to reach US$ 5 billion by the end of 2027.
Medical device complaint management market is expected to garner a market value of US$ 5.35 Bn in 2022, anticipated to register a positive CAGR of 7% in the forecast period 2022-2032 and reach a value of US$ 10.52 Bn.
Brain implants market is valued at US$ 6.6 billion in 2022 and is predicted to expand at a high-value CAGR of 11% to reach US$ 11.1 billion by the year 2027.
Cardiovascular repair and reconstruction devices market is valued at US$ 4.2 billion in 2022 and is expected to reach a market size of US$ 5.5 billion by 2027.
Nerve repair and regeneration market is projected to rise at a stellar CAGR of 11% from 2022 to 2026. Currently, the market is valued at US$ 8 billion and is anticipated to reach US$ 12 billion by the end of 2026.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
